Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Dexmethylphenidate hydrochloride by Cingulate for Attention Deficit Hyperactivity Disorder (ADHD): Likelihood of Approval
Dexmethylphenidate hydrochloride is under clinical development by Cingulate and currently in Phase III for Attention Deficit Hyperactivity Disorder (ADHD). According...
Data Insights
Dexmethylphenidate hydrochloride by Cingulate for Attention Deficit Hyperactivity Disorder (ADHD): Likelihood of Approval
Dexmethylphenidate hydrochloride is under clinical development by Cingulate and currently in Phase III for Attention Deficit Hyperactivity Disorder (ADHD). According...